TGF-alpha immunoreactivity in laryngeal carcinoma: Lack of prognostic value and correlation to EGF-receptor expression

Australian and New Zealand Journal of Surgery

Volumn 66, Issue 7, 1996, Pages 464-468

  Lee, C Soon ^a,c   Redshaw, Anna ^a   Boag, Guy ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

^c ST GEORGE HOSPITAL   (Australia)

Author keywords

EGF receptor; immunohistochemistry; laryngeal neoplasms; TGF ; tumour markers; tyrosine kinase

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; PROTEIN ANTIBODY; PROTEIN TYROSINE KINASE; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LARYNX CARCINOMA; LARYNX PAPILLOMATOSIS; MALE; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

EID: 0029999803     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.1996.tb00783.x     Document Type: Article

References (35)

1. Coates M, Day P, McCredie M, Taylor R. Cancer in New South Wales. Incidence und Mortality. Kings Cross, NSW: NSW Cancer Council, 1992; 70-96.
2. Jhappan C, Stahl C, Harkins RN et al. TGF-α overexpression in transgenic mice induces liver neoplasia and abnormal development of mammary gland and pancreas. Cell 1990; 61: 1137-46.
3. Sandgren EP, Luetteke NC, Palmiter RD et al. Overexpression of TGF-α in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 1990; 61: 1121-35.
4. Dublin EA, Barnes DM, Wang DY, King RJB, Levison DA. TGF alpha and TGF beta expression in mammary carcinoma. J. Pathol. 1993; 170: 15-22.
5. Schaff Z, Hsia CC, Sarosi I, Tabor E. Overexpression of transforming growth factor-alpha in hepatocellular carcinoma and focal nodular hyperplasia from European patients. Hum. Pathol. 1994; 25: 644-51.
6. Park BC, Huh MH, Seo JH. Differential expression of transforming growth factor-alpha and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma. J. Hepatol. 1995; 22: 286-94.
7. Christensen ME, Therkildsen MH, Poulsen SS, Bretlau P. Immunoreactive transforming growth factor alpha and epidermal growth factor in oral squamous cell carcinomas. J. Pathol. 1993; 169: 323-8.
8. Pecur L, Kapitanovic S, Sonicki Z et al. Prognostic significance of transforming growth factor alpha (TGF-alpha) in human lung carcinoma: An immunohistochemical study. Anticancer Res. 1994; 14: 2839-43.
9. Morocz IA, Schmitter D, Lauber B, Stahel RA. Autocrine stimulation of a human lung mesothelioma cell line is mediated through the transforming growth factor alpha/epidermal growth factor receptor mitogenic pathway. Br. J. Cancer 1994; 70: 850-6.
10. Lager DJ, Slagel DD, Palechek PL. The expression of transforming growth factor alpha in renal cell carcinoma. Mod. Pathol. 1994; 7: 544-8.
11. Barton CM, Hall PA, Hughes CM, Gullick WJ, Lemoine NR. Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J. Pathol. 1991; 163: 111-16.
12. Nilsson O, Wangberg B, Kolby L, Schultz GS, Ahlman H. Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours. Int. J. Cancer 1995; 60: 645-51.
13. Moskal TL, Huang S, Ellis LM, Fritsche HA Jr. Chakrabarty S. Serum levels of transforming growth factor alpha in gastrointestinal cancer patients. Cancer Epidemiol. Biomarkers Prevent. 1995; 4: 127-31.
14. Gregory H. Isolation and structure of urogastrone. Nature 1975; 257: 325-7.
15. Derynck R, Robert AB, Winkler LE, Chen EY, Goeddel DV. Human transforming growth factor alpha: Precursor structure and expression in E. coli. Cell 1984; 38: 287-97.
16. Todaro GJ, Fryling C, De Larco JE. Transforming growth factors produced by certain human tumor cells: Polypeptides that interact with epidermal growth factor receptors. Proc. Natl. Acad. Sci. U.S.A. 1980; 77: 5258-62.
17. Massagué J. Epidermal growth factor like transforming growth factor. Interaction with epidermal growth factor receptors in human placental membranes and A431 cells. J. Biol. Chem. 1983; 258: 13614-20.
18. Rosenthal A, Lundquist PB, Bringman TS, Goeddel DV, Derynck R. Expression in rat fibroblasts of a human transforming growth factor-alpha cDNA results in transformation. Cell 1986; 46: 301-9.
19. Lee CS, Redshaw A, Boag G. Epidermal growth factor receptor immunoreactivity in human laryngeal squamous cell carcinoma (in press).
20. De Larco J, Todaro G. Growth factors from murine sarcoma virus-transformed cells. Proc. Natl. Acad. Sci. U.S.A. 1978; 75: 4001-5.
21. Twardzik DR, Ranchalis JE, Todaro J. Mouse embryonic transforming growth factors related to those isolated from tumor cells. Cancer Res. 1982; 42: 590-3.
22. Roberts AB, Anzano MA, Lamb LC et al. New class of transforming growth factors potentiated by epidermal growth factor: Isolation from non-neoplastic tissues. Proc. Natl. Acad. Sci. U.S.A. 1981; 78: 5339-43.
23. Malden LT, Novak U, Burgess AW. Expression of transforming growth factor-alpha messenger RNA in the normal and neoplastic gastrointestinal tract. Int. J. Cancer 1989; 43: 380-4.
24. Smith JJ, Derynck R, Korc M. Production of transforming growth factor-alpha in human pancreatic cancer cells: Evidence for a superagonist cycle. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 7567-70.
25. Chen YF, Pan G-Z, Hou X et al. Epidermal growth factor and its receptor in human pancreatic carcinoma. Pancreas 1990; 5: 278-83.
26. Christensen ME, Therkildsen MH, Hansen BL, Hansen GN, Bretlau P. Immunohistochemical detection of epidermal growth factor receptor in laryngeal squamous cell carcinomas. Acta Otolaryngol (Stockh.) 1992; 112: 734-8.
27. Miyaguchi M, Olofsson J, Hellquist HB. Immunohistochemical study of epidermal growth factor receptor in severe dysplasia and carcinoma in situ of the vocal cords. Acta Otolaryngol. (Stockh.) 1991; 11: 149-52.
28. Arteaga CL, Hanauske AR, Clark GM et al. Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis. Cancer Res. 1988; 48: 5023-8.
29. Christensen ME, Therkildsen MH, Poulsen SS, Bretlau P. Transforming growth factor alpha and epidermal growth factor in laryngeal carcinomas demonstrated by immunohistochemistry. Acta Otolaryngol. (Stockh.) 1993; 113: 563-7.
30. Di Marco E, Albanese E, Benso S, Beatrice F, Cancedda R, Toma S. Expression of epidermal growth factor receptor and transforming growth factor alpha in human larynx carcinoma. Cancer Letters 1992; 65: 189-99.
31. Santini D, Ceccarelli C, Martinelli GN et al. Immunocytochemical study of epidermal growth factor receptor, transforming growth factor alpha, and 'squamous differentiation' in human endometrial carcinoma. Hum. Pathol. 1994; 25: 1319-23.
32. Coffey RJ, Sipes NJ, Bascom CC et al. Growth modulation of mouse keratinocytes by transforming growth factors. Cancer Res. 1988; 48: 1596-1602.
33. Carpenter G, Zendegui JG. Epidermal growth factor, its receptor and related proteins. Exp. Cell Res. 1986; 164: 1-10.
34. Weinberg RA. Oncogenes, anti-oncogenes and the molecular hases of multistep carcinogenesis. Cancer Res. 1989; 49: 3713-21.
35. Wynford-Thomas D. Oncogenes and anti-oncogenes: The molecular basis of tumour behaviour. J. Pathol. 1991; 165: 187-201.